The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice
- 13 March 2000
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 391 (1-2) , 91-96
- https://doi.org/10.1016/s0014-2999(00)00049-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Heroin Antinociception Changed From Mu to Delta Receptor in Streptozotocin-Treated MiceThe Japanese Journal of Pharmacology, 1998
- A potent and selective endogenous agonist for the µ-opiate receptorNature, 1997
- Supraspinal δ1-opioid receptor-mediated antinociceptive properties of (−)-TAN-67 in diabetic miceEuropean Journal of Pharmacology, 1997
- Spinal Delta Opioid Receptor Subtype Activity of 6-monoacetylmorphine in Swiss Webster MicePharmacology Biochemistry and Behavior, 1997
- Antinociceptive effects of the selective non-peptidic δ-opioid receptor agonist TAN-67 in diabetic miceEuropean Journal of Pharmacology, 1995
- Streptozotocin-induced diabetes selectively enhances antinociception mediated by δ1-but not δ2-opioid receptorsLife Sciences, 1994
- Supraspinal delta receptor subtype activity of heroin and 6-monoacetylmorphine in Swiss webster miceLife Sciences, 1994
- Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of δ-opioid receptorsBrain Research, 1992
- Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic miceBrain Research, 1992
- Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonistsBrain Research, 1992